September 2, 2019 / 5:06 AM / 18 days ago

BRIEF-Roche Presents Positive Study Results For One-Dose Xofluza In Children With Flu

Sept 2 (Reuters) - Roche Holding AG:

* ROCHE PRESENTS POSITIVE PHASE III STUDY RESULTS FOR ONE-DOSE XOFLUZA IN CHILDREN WITH FLU

* XOFLUZA WAS ADMINISTERED AS A NEW ONE-DOSE ORAL SUSPENSION, A POTENTIALLY MORE CONVENIENT TREATMENT OPTION FOR CHILDREN

* XOFLUZA WAS COMPARABLE TO OSELTAMIVIR IN RELATION TO KEY SECONDARY ENDPOINTS, INCLUDING TIME TO ALLEVIATION OF INFLUENZA SIGNS AND SYMPTOMS (MEDIAN 138.1 HOURS VERSUS. 150.0 HOURS) Source text for Eikon: Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below